TipRanks
US Nuclear Corp. (UCLE)
OTHER OTC:UCLE
US Market
Want to see UCLE full AI Analyst Report?

US Nuclear (UCLE) AI Stock Analysis

76 Followers

Top Page

UCLE

US Nuclear

(OTC:UCLE)

Select Model
Select Model
Select Model
Neutral 41 (OpenAI - Gpt-5.6Sol)
Rating:41Neutral
Price Target:
$0.02
▲(0.00% Upside)
Action:Reiterated
Date:09/19/26
UCLE’s score is held down primarily by weak financial performance—ongoing losses, negative free cash flow, and negative equity—despite improving gross margin, narrowing losses, reduced cash burn, and lower debt in 2025. Technicals add additional pressure with a clear downtrend (price below key moving averages) and weak momentum (negative MACD, RSI ~37). Valuation provides limited offset because the negative P/E reflects unprofitability and there is no dividend yield support.
Positive Factors
Diversified radiation-equipment applications
Serving multiple radiation-detection applications gives UCLE several potential end markets rather than reliance on one use case. This breadth can support durable demand diversification and create opportunities to adapt instruments and monitoring systems across regulated and industrial customers over the next several quarters.
Negative Factors
Persistent structural unprofitability
UCLE remains materially below breakeven despite narrower losses, so revenue and gross profit are not yet sufficient to cover the full operating cost base. Continued net and operating losses can constrain investment, weaken resilience, and delay the development of a self-sustaining business model.
Read all positive and negative factors
Positive Factors
Negative Factors
Diversified radiation-equipment applications
Serving multiple radiation-detection applications gives UCLE several potential end markets rather than reliance on one use case. This breadth can support durable demand diversification and create opportunities to adapt instruments and monitoring systems across regulated and industrial customers over the next several quarters.
Read all positive factors

US Nuclear (UCLE) vs. SPDR S&P 500 ETF (SPY)

US Nuclear Business Overview & Revenue Model

Company Description
US Nuclear Corp. (UCLE) is a global entity dedicated to the engineering, production, and sale of advanced radiation detection and measurement technologies. The company conducts its operations through two primary divisions: Optron and Overhoff. Its...
How the Company Makes Money
U.S. Nuclear primarily makes money by selling radiation detection and monitoring products and related systems to customers that require measurement of ionizing radiation. Revenue is generated from product sales (e.g., detectors, meters, monitors, ...

US Nuclear Financial Statement Overview

Summary
Financial strength is weak despite some 2025 operational improvement. Revenue was relatively stable with a rebound in 2025 and gross margin improved to ~50%, and losses/cash burn narrowed. However, the company remains structurally unprofitable with negative operating results and persistently negative operating/free cash flow, and negative shareholders’ equity (2022–2025) is a major balance-sheet risk even though debt declined in 2025.
Income Statement
24
Negative
Balance Sheet
18
Very Negative
Cash Flow
22
Negative
BreakdownDec 2025Dec 2024Dec 2023Mar 2023Mar 2022
Income Statement
Total Revenue2.17M2.19M2.23M2.09M2.14M
Gross Profit1.09M1.02M924.31K788.07K1.38M
EBITDA-1.40M-1.51M-1.78M-1.49M-1.81M
Net Income-1.24M-1.74M-3.43M-2.04M-1.88M
Balance Sheet
Total Assets1.92M2.65M2.86M3.11M2.85M
Cash, Cash Equivalents and Short-Term Investments134.78K130.84K152.84K126.11K246.32K
Total Debt916.32K1.78M2.24M1.60M910.27K
Total Liabilities2.44M3.50M4.84M3.46M2.41M
Stockholders Equity-513.69K-856.16K-1.98M-348.30K441.27K
Cash Flow
Free Cash Flow-199.34K-509.05K-264.30K-1.32M-447.47K
Operating Cash Flow-199.34K-509.05K-263.44K-1.32M-441.03K
Investing Cash Flow0.00-30.77K-24.55K0.00-21.45K
Financing Cash Flow203.28K517.82K314.72K1.20M481.49K

US Nuclear Risk Analysis

US Nuclear disclosed 33 risk factors in its most recent earnings report. US Nuclear reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

US Nuclear Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
64
Neutral
$86.27M-350.00-0.53%26.35%-130.90%
61
Neutral
$37.18B12.37-10.20%1.83%8.50%-7.62%
50
Neutral
$13.77M1.6834.15%-21.65%
47
Neutral
$77.75M873.910.15%25.56%
46
Neutral
$37.81M-15.29-5.77%1.53%-28.46%-147.43%
41
Neutral
$1.51M-0.87275.26%-0.98%33.93%
* Technology Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
UCLE
US Nuclear
0.02
-0.03
-58.00%
LGL
LGL Group
7.00
0.21
3.06%
MIND
MIND Technology
4.01
-4.86
-54.79%
NEON
Neonode
0.82
-3.33
-80.19%
CPSH
CPS Technologies
4.02
0.37
10.14%
IMTE
Integrated Media Technology
0.51
-0.62
-54.69%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Sep 19, 2026